Benjamin Burnett
Stock Analyst at Wells Fargo
(0.13)
# 4,759
Out of 5,090 analysts
448
Total ratings
35.3%
Success rate
-6.5%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Reiterated: Buy | $109 → $112 | $59.97 | +86.76% | 11 | Oct 30, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $64 | $37.41 | +71.08% | 15 | Oct 29, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $14 | $3.59 | +289.97% | 11 | Oct 28, 2026 | |
| RAPP Rapport Therapeutics | Rated: Buy | $51 → $50 | $25.05 | +99.60% | 5 | Oct 21, 2026 | |
| MNKD MannKind | Reiterated: Buy | $13 | $3.50 | +271.43% | 10 | Oct 19, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Hold | $362 | $285.93 | +26.60% | 8 | Oct 16, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $700 | $598.72 | +16.92% | 13 | Oct 16, 2026 | |
| LQDA Liquidia | Reiterated: Hold | $30 → $33 | $45.06 | -26.76% | 12 | Oct 14, 2026 | |
| INSM Insmed | Rated: Buy | $169 | $112.58 | +50.12% | 10 | Oct 13, 2026 | |
| AXSM Axsome Therapeutics | Rated: Buy | $256 | $144.43 | +77.25% | 11 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $19.78 | +370.17% | 5 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 | $16.10 | +11.80% | 12 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $27.72 | -27.85% | 3 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.04 | +63.04% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $11.57 | +12.36% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $36.33 | +98.18% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $20.86 | +110.93% | 2 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $9 | $4.82 | +86.72% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $45.34 | +43.36% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $64 | $191.31 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $13 | $1.51 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.94 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $1.18 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $8.48 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $8.01 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $2.08 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $92 | $80.84 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $0.5202 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $49 | $51.42 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $64 | $31.96 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $7.06 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.9 → $3.6 | $0.116 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.7 → $3 | $38.87 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $27.55 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.000001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $27.23 | n/a | 2 | Feb 28, 2022 |
PTC Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $109 → $112
Current: $59.97
Upside: +86.76%
Xenon Pharmaceuticals
Oct 29, 2026
Reiterated: Buy
Price Target: $64
Current: $37.41
Upside: +71.08%
Wave Life Sciences
Oct 28, 2026
Reiterated: Buy
Price Target: $14
Current: $3.59
Upside: +289.97%
Rapport Therapeutics
Oct 21, 2026
Rated: Buy
Price Target: $51 → $50
Current: $25.05
Upside: +99.60%
MannKind
Oct 19, 2026
Reiterated: Buy
Price Target: $13
Current: $3.50
Upside: +271.43%
Praxis Precision Medicines
Oct 16, 2026
Reiterated: Hold
Price Target: $362
Current: $285.93
Upside: +26.60%
United Therapeutics
Oct 16, 2026
Reiterated: Buy
Price Target: $700
Current: $598.72
Upside: +16.92%
Liquidia
Oct 14, 2026
Reiterated: Hold
Price Target: $30 → $33
Current: $45.06
Upside: -26.76%
Insmed
Oct 13, 2026
Rated: Buy
Price Target: $169
Current: $112.58
Upside: +50.12%
Axsome Therapeutics
Oct 1, 2026
Rated: Buy
Price Target: $256
Current: $144.43
Upside: +77.25%
Sep 29, 2026
Rated: Buy
Price Target: $93
Current: $19.78
Upside: +370.17%
Sep 18, 2026
Rated: Hold
Price Target: $18
Current: $16.10
Upside: +11.80%
Sep 2, 2026
Reiterated: Hold
Price Target: $20
Current: $27.72
Upside: -27.85%
Sep 2, 2026
Reiterated: Buy
Price Target: $18
Current: $11.04
Upside: +63.04%
Aug 31, 2026
Reiterated: Hold
Price Target: $13
Current: $11.57
Upside: +12.36%
Aug 31, 2026
Reiterated: Buy
Price Target: $72
Current: $36.33
Upside: +98.18%
Aug 31, 2026
Reiterated: Buy
Price Target: $44
Current: $20.86
Upside: +110.93%
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $4.82
Upside: +86.72%
Jul 29, 2026
Rated: Buy
Price Target: $65
Current: $45.34
Upside: +43.36%
Apr 1, 2025
Reiterated: Buy
Price Target: $78 → $64
Current: $191.31
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $26 → $13
Current: $1.51
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $6.94
Upside: n/a
Mar 17, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $1.18
Upside: n/a
Mar 17, 2025
Reiterated: Buy
Price Target: $18
Current: $8.48
Upside: n/a
Mar 11, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $8.01
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $2.08
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $94 → $92
Current: $80.84
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $80
Current: $0.5202
Upside: n/a
Feb 13, 2025
Reiterated: Hold
Price Target: $53 → $49
Current: $51.42
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $66 → $64
Current: $31.96
Upside: n/a
Apr 19, 2024
Reiterated: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Reiterated: Buy
Price Target: $42
Current: $7.06
Upside: n/a
Aug 10, 2023
Reiterated: Hold
Price Target: $3.9 → $3.6
Current: $0.116
Upside: n/a
Mar 2, 2023
Reiterated: Hold
Price Target: $4.7 → $3
Current: $38.87
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $27.55
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.000001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $27.23
Upside: n/a